tiprankstipranks

Luke Miels Insider Profile

4 Followers
Luke Miels, Executive Vice-President at AstraZeneca, holds ― shares in GlaxoSmithKline (Ticker: GB:GSK), holds ― shares in AstraZeneca (Ticker: GB:AZN).
tipranks
Luke Miels

Luke Miels
AstraZeneca (AZN)
Executive Vice-President

Ranked #75,927 out of 106,487 Corporate Insiders

Profitable Transactions

44%
4 out of 9 Profitable Transactions

Average Return

-9.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

Luke Miels does not currently own shares as a corporate insider.
A breakdown of Luke Miels's holdings

Insider Roles

AstraZeneca
(AZN)
Executive Vice-President
GlaxoSmithKline
(GSK)
Chief Executive Officer
Roles that Luke Miels holds in companies

Most Profitable Insider Trade

Stock:
GlaxoSmithKline
(GSK)
Rating:Informative Sell
Date:Feb 15, 2024 - Feb 15, 2025
Return:+10.30%
The most profitable trade made by Luke Miels

Luke Miels's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
AstraZeneca
May 23, 2016
Executive Vice-President
Uninformative Buy
GlaxoSmithKline
Apr 16, 2026
Chief Executive Officer
Uninformative Buy
25.53K
List of latest transactions for each holding click on a transaction to see Luke Miels's performance on stock

Luke Miels insider profile FAQ

What is the percentage of profitable transactions made by Luke Miels?
The percentage of profitable transactions made by Luke Miels is 44%.
    What is the average return per transaction made by Luke Miels?
    The average return per transaction made by Luke Miels is -9.30%.
      What stocks does Luke Miels hold?
      Luke Miels holds: GB:AZN, GB:GSK stocks.
        What was Luke Miels’s latest transaction?
        Luke Miels latest transaction was an Uninformative Buy of 25.53K .
          What was Luke Miels's most profitable transaction?
          Luke Miels’s most profitable transaction was an Informative Sell of GB:GSK stock on February 15, 2024. The return on the trade was 10.30%.
            What is Luke Miels's role in AstraZeneca?
            Luke Miels's role in AstraZeneca is Executive Vice-President.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.